Ovestin, introduced in 1957, contains the natural hormone estriol, which is a weak estrogen «with only minimal systemic effects. Ovestin can thus treat urogenital complaints without the ‘need for further medication and without the risk of additional side effects. As well as treating symptoms, the treatment has a preventive effect, having been shown to increase resistance to vaginal infection and inflammation. The absence of progestogen-induced withdrawal bleeds with Ovestin makes it an acceptable treatment and prevention therapy for many women.

The details

Ovestin is used to treat urogenital symptoms without causing adverse changes to the endometrium, the glandular mucous membrane that lines the uterus. Ovestin is available in three formulations—tablets, cream and pessaries—allowing patients to select the most suitable method. A marked therapeutic effect typically occurs within several weeks of administration.

Indications

Ovestin is typically prescribed in cases of estrogen deficiency in post-menopausal women, resulting in recurrent infections of the vagina and lower urinary tract and also mild urinary incontinence.

Availability

Ovestin is currently registered in more than 65 countries.

The following related products are also available from Organon:

• Andriol®
• Livial®
• Riselle®